Genetic immune and inflammatory markers associated with diabetes in solid organ transplant recipients.

Quteineh, Lina; Wójtowicz, Agnieszka; Bochud, Pierre-Yves; Crettol, Severine; Vandenberghe, Frederik; Venetz, Jean-Pierre; Manuel, Oriol; Golshayan, Dela; Lehmann, Roger; Mueller, Nicolas J; Binet, Isabelle; van Delden, Christian; Steiger, Jürg; Mohacsi, Paul; Dufour, Jean-François; Soccal, Paola M; Kutalik, Zoltan; Marques-Vidal, Pedro; Vollenweider, Peter; Recher, Mike; ... (2019). Genetic immune and inflammatory markers associated with diabetes in solid organ transplant recipients. American journal of transplantation, 19(1), pp. 238-246. Wiley-Blackwell 10.1111/ajt.14971

[img] Text
Quteineh_et_al-2018-American_Journal_of_Transplantation.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (478kB) | Request a copy

New-onset diabetes mellitus after transplantation (NODAT) is a complication following solid organ transplantation (SOT) and may be related to immune or inflammatory responses. We investigated whether single nucleotide polymorphisms (SNPs) within 158 immune- or inflammation-related genes contribute to NODAT in SOT recipients. The association between 263 SNPs and NODAT was investigated in a discovery sample of SOT recipients from the Swiss Transplant Cohort Study (STCS, n  = 696). Positive results were tested in a first STCS replication sample (n  = 489) and SNPs remaining significant after multiple test corrections were tested in a second SOT replication sample (n  = 156). Associations with diabetic traits were further tested in several large general population-based samples (n > 480 000). Only SP110 rs2114592C>T remained associated with NODAT in the STCS replication sample. Carriers of rs2114592-TT had 9.9 times (95% confidence interval [CI]: 3.22-30.5, P = .00006) higher risk for NODAT in the combined STCS samples (n = 1184). rs2114592C>T was further associated with NODAT in the second SOT sample (odds ratio: 4.8, 95% CI: 1.55-14.6, P = .006). On the other hand, SP110 rs2114592C>T was not associated with diabetic traits in population-based samples, suggesting a specific gene-environment interaction, possibly due to the use of specific medications (ie, immunosuppressants) in transplant patients and/or to the illness that may unmask the gene effect.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Gastro-intestinal, Liver and Lung Disorders (DMLL) > Clinic of Visceral Surgery and Medicine > Hepatology
04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > DBMR Forschung Mu35 > Forschungsgruppe Hepatologie
04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > DBMR Forschung Mu35 > Forschungsgruppe Hepatologie

UniBE Contributor:

Dufour, Jean-François

Subjects:

600 Technology
600 Technology > 610 Medicine & health

ISSN:

1600-6135

Publisher:

Wiley-Blackwell

Language:

English

Submitter:

Thi Thao Anh Pham

Date Deposited:

20 Feb 2019 15:58

Last Modified:

05 Dec 2022 15:18

Publisher DOI:

10.1111/ajt.14971

PubMed ID:

29920932

Uncontrolled Keywords:

clinical research/practice diabetes genetics new onset/posttransplant

BORIS DOI:

10.7892/boris.120171

URI:

https://boris.unibe.ch/id/eprint/120171

Actions (login required)

Edit item Edit item
Provide Feedback